Literature DB >> 33340286

Blocking myostatin: muscle mass equals muscle strength?

Markus S Anker1,2,3,4, Stephan von Haehling5, Jochen Springer1,2.   

Abstract

Entities:  

Year:  2020        PMID： 33340286     DOI： 10.1002/jcsm.12647

Source DB:  PubMed          Journal:  J Cachexia Sarcopenia Muscle        ISSN： 2190-5991            Impact factor:   12.910


× No keyword cloud information.
  4 in total

Review 1.  Biomarkers of Myocardial Injury and Remodeling in Heart Failure.

Authors:  Barbara Ponikowska; Gracjan Iwanek; Agata Zdanowicz; Szymon Urban; Robert Zymliński; Piotr Ponikowski; Jan Biegus
Journal:  J Pers Med       Date:  2022-05-16

Review 2.  Molecular Mechanisms and Current Treatment Options for Cancer Cachexia.

Authors:  Syed Sayeed Ahmad; Khurshid Ahmad; Sibhghatulla Shaikh; Hye Jin You; Eun-Young Lee; Shahid Ali; Eun Ju Lee; Inho Choi
Journal:  Cancers (Basel)       Date:  2022-04-23       Impact factor: 6.575

Review 3.  Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments.

Authors:  Juha J Hulmi; Tuuli A Nissinen; Fabio Penna; Andrea Bonetto
Journal:  Cells       Date:  2021-02-28       Impact factor: 6.600

4.  Determining the contributions of protein synthesis and breakdown to muscle atrophy requires non-steady-state equations.

Authors:  Kamil A Kobak; Marcus M Lawrence; Gavin Pharaoh; Agnieszka K Borowik; Frederick F Peelor; Patrick D Shipman; Timothy M Griffin; Holly Van Remmen; Benjamin F Miller
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-08-21       Impact factor: 12.910
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.